MiMedx Group, Inc. (MDXG)
Automate Your Wheel Strategy on MDXG
With Tiblio's Option Bot, you can configure your own wheel strategy including MDXG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDXG
- Rev/Share 2.3927
- Book/Share 1.3769
- PB 4.2851
- Debt/Equity 0.092
- CurrentRatio 4.6954
- ROIC 0.1727
- MktCap 871441800.0
- FreeCF/Share 0.4639
- PFCF 12.7557
- PE 21.6248
- Debt/Assets 0.069
- DivYield 0
- ROE 0.2158
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 3
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
MIMEDX to Present at the BofA Securities 2025 Healthcare Conference
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARIETTA, Ga., May 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV.
Read More
MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Matthew Notarianni - Head, IR Joseph Capper - CEO & Director Doug Rice - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets Chase Knickerbocker - Craig-Hallum Capital Group Ross Osborn - Cantor Fitzgerald Anthony Petrone - Mizuho Group Operator Good afternoon, and thank you for standing by. Welcome to the MIMEDX First Quarter 2025 Operating and Financial Results Conference Call.
Read More
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
MARIETTA, Ga., Feb. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 45th Annual Health Care Conference.
Read More
MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
MiMedx Group, Inc. (NASDAQ:MDXG ) Q4 2024 Earnings Conference Call February 26, 2024 4:30 AM ET Company Participants Matt Notarianni - Head, Investor Relations Joseph Capper - Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Group Ross Osborn - Cantor Fitzgerald Bradley Bowers - Mizuho Securities Brooks O'Neil - Lake Street Capital Markets Carl Byrnes - Northland Capital Markets Operator Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2024 Operating Financial Results Conference Call.
Read More
MiMedx (MDXG) Q4 Earnings Meet Estimates
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
MiMedx (MDXG) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago.
Read More
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Net Sales Grew 7% Year-Over-Year for the Fourth Quarter and 9% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $7 million and $0.05, Respectively Fourth Quarter Adjusted EBITDA¹ was $20 Million, or 21% of Net Sales Management to Host Conference Call Today, February 26, 2025, at 4:30 PM ET MARIETTA, Ga., Feb. 26, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the fourth quarter and full year 2024.
Read More
About MiMedx Group, Inc. (MDXG)
- IPO Date 2008-02-12
- Website https://www.mimedx.com
- Industry Biotechnology
- CEO Mr. Joseph H. Capper
- Employees 837